# Bayer (New Zealand)

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/bayer-new-zealand/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 57.3 |
| Citations | 67,981 |
| City | Auckland |
| Country | NZ |
| Description | Bayer (New Zealand) is a research organisation in Auckland, NZ. OpenAlex records 1,259 works and 67,981 citations for it. 66 researchers list it as their most recent affiliation. |
| Homepage | http://www.bayeranimal.co.nz/en/ |
| OpenAlex ID | https://openalex.org/I4210104644 |
| Researchers | 66 |
| ROR ID | https://ror.org/01ezy0w74 |
| Type | company |
| Works | 1,259 |

## University papers

Showing 12 of 22.

- [A Pharmacokinetic Standard for Babies and Adults](https://scholariq.org/papers/a-pharmacokinetic-standard-for-babies-and-adults/)
- [Golodirsen: First Approval](https://scholariq.org/papers/golodirsen-first-approval/)
- [Sotorasib: First Approval](https://scholariq.org/papers/sotorasib-first-approval/)
- [Baloxavir: First Global Approval](https://scholariq.org/papers/baloxavir-first-global-approval/)
- [Pyrotinib: First Global Approval](https://scholariq.org/papers/pyrotinib-first-global-approval/)
- [Abatacept: A Review in Rheumatoid Arthritis](https://scholariq.org/papers/abatacept-a-review-in-rheumatoid-arthritis/)
- [Efgartigimod: First Approval](https://scholariq.org/papers/efgartigimod-first-approval/)
- [Belimumab: A Review in Systemic Lupus Erythematosus](https://scholariq.org/papers/belimumab-a-review-in-systemic-lupus-erythematosus/)
- [Tofersen: First Approval](https://scholariq.org/papers/tofersen-first-approval/)
- [Pegaspargase: A Review in Acute Lymphoblastic Leukaemia](https://scholariq.org/papers/pegaspargase-a-review-in-acute-lymphoblastic-leukaemia/)
- [Duvelisib: First Global Approval](https://scholariq.org/papers/duvelisib-first-global-approval/)
- [Secukinumab: A Review in Ankylosing Spondylitis](https://scholariq.org/papers/secukinumab-a-review-in-ankylosing-spondylitis/)

## University researchers

- [Hannah A. Blair](https://scholariq.org/researchers/hannah-a-blair/)
- [Young‐A Heo](https://scholariq.org/researchers/young-a-heo/)

## University top topics

Showing 8 of 25.

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [CAR-T cell therapy research](https://scholariq.org/topics/car-t-cell-therapy-research/)
- [Chronic Lymphocytic Leukemia Research](https://scholariq.org/topics/chronic-lymphocytic-leukemia-research/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Lymphoma Diagnosis and Treatment](https://scholariq.org/topics/lymphoma-diagnosis-and-treatment/)
- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Cancer therapeutics and mechanisms](https://scholariq.org/topics/cancer-therapeutics-and-mechanisms/)
- [Multiple Myeloma Research and Treatments](https://scholariq.org/topics/multiple-myeloma-research-and-treatments/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.